News
INTRODUCING BIODGRAFT: A SOLUTION FOR LIFE
PRESS RELEASE September 27, 2022 BioDGraft, an NLC venture, sets out to eliminate the need for vein harvesting in bypass surgeries, proposing a solution…
INTRODUCING AIDO: BUILDING THE FUTURE PLATFORM FOR INTERVENTIONAL ENDOSCOPY
PRESS RELEASE September 8, 2022 AIDO, an NLC venture, has made it its mission to bring more control to physicians performing endoscopic procedures and…
NLC Collaborates with FFUND and ttopstart to accelerate growth of healthtech ventures
PRESS RELEASE AUGUST 22, 2022 NLC – The European Healthtech Venture Builder, FFUND and ttopstart partner to accelerate the growth of life-saving healthcare ventures…
Haermonics Series A funding offers Pure™ promise for future heart surgery patients
Eindhoven, the Netherlands, August 2, 2022 Haermonics, a clinical-stage breakthrough medtech company, has successfully closed a 4.3 M Series-A financing round with an investment…
Introducing AETHERUS: offering rapid relief to those suffering from breathlessness
PRESS RELEASE July 15, 2022 AETHERUS, an NLC venture, sets out to improve the quality of life of patients suffering from Chronic Obstructive Pulmonary…
Bright times ahead for SuperSeton
PRESS RELEASE May 2022 For the second year in a row, SuperSeton has been selected as one of 29 initiatives to join the EITHealth…
Allergios closes their latest round of seed financing
This spring, the seeds are flying for Allergios Allergios – a biomedical start-up with an innovative allergy test that produces unprecedented accurate results –…
Investment in ARNE helps neonatologists treat newborn babies
PRESS RELEASE April 26, 2022 ARNE B.V. has raised financing from Oost NL and venture builder NLC. ARNE supplies smart software with which neonatologists…
Charles River Laboratories and NLC Collaborate
PRESS RELEASE April 2022 NLC – The European Healthtech Venture Builder and Charles River Laboratories team up to drive drug discovery projects towards finding…
Scinvivo secures 1 Million investment for in human clinical trials & CE
Press Release Eindhoven, March 10th, 2022 Scinvivo 1 million investment secured towards in human clinical trials & CE for game-changing cancer diagnostics Scinvivo, a…
Hemeo raises €675,000 in an oversubscribed seed equity round
Hemeo announces the successful closure of its first equity finance round. Raising €675,000, it has been substantially oversubscribed, highlighting the strong interest raised by…
Bilihome successfully closes an investment round for smart, wearable light therapy for newborns with jaundice
PRESS RELEASE Bilihome successfully closes an investment round for smart, wearable light therapy for newborns with jaundice Margret Huenerbein, m.huenerbein@bilihome.org, www.bilihome.org Nijkerk, the Netherlands…